Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on June 25, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). June 23, 2026 press release announced expiration and final results of Exchange Offers and Consent Solicitations.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- June 23, 2026 press release announced expiration and final results of Exchange Offers and Consent Solicitations
- Final settlement details incorporated by reference from the Explanatory Note and Exhibit 99.1
- Investor impact depends on exchange participation and consent outcomes disclosed in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- 99.9% of 2029 Notes and 99.2% of 2030 Notes tendered, indicating near-universal creditor participation
- $911.1 million Existing Notes exchanged for $213.0 million First Lien and $698.1 million Second Lien Notes
- $326.25 million New Money Notes issued, bringing total First Lien Notes to $539.25 million
- Capital structure shifts toward secured debt, potentially improving liquidity while increasing senior claims on assets
- New Notes unregistered, restricted to qualified institutional buyers and non-U.S. investors under Rule 144A or Regulation S
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.